Innoviva Statistics
Total Valuation
Innoviva has a market cap or net worth of $1.56 billion. The enterprise value is $1.24 billion.
| Market Cap | 1.56B |
| Enterprise Value | 1.24B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 73.81 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 73.81M |
| Shares Outstanding | 73.81M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -13.47% |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 101.68% |
| Float | 69.20M |
Valuation Ratios
The trailing PE ratio is 4.90 and the forward PE ratio is 8.80. Innoviva's PEG ratio is 0.25.
| PE Ratio | 4.90 |
| Forward PE | 8.80 |
| PS Ratio | 3.54 |
| Forward PS | 3.37 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.49 |
| P/FCF Ratio | 8.22 |
| P/OCF Ratio | 8.14 |
| PEG Ratio | 0.25 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.10, with an EV/FCF ratio of 6.53.
| EV / Earnings | 3.46 |
| EV / Sales | 2.81 |
| EV / EBITDA | 6.10 |
| EV / EBIT | 7.61 |
| EV / FCF | 6.53 |
Financial Position
The company has a current ratio of 16.01, with a Debt / Equity ratio of 0.21.
| Current Ratio | 16.01 |
| Quick Ratio | 14.65 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.27 |
| Debt / FCF | 1.36 |
| Interest Coverage | 8.92 |
Financial Efficiency
Return on equity (ROE) is 36.68% and return on invested capital (ROIC) is 14.45%.
| Return on Equity (ROE) | 36.68% |
| Return on Assets (ROA) | 6.89% |
| Return on Invested Capital (ROIC) | 14.45% |
| Return on Capital Employed (ROCE) | 9.82% |
| Weighted Average Cost of Capital (WACC) | 6.09% |
| Revenue Per Employee | $2.77M |
| Profits Per Employee | $2.25M |
| Employee Count | 159 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 2.77 |
Taxes
In the past 12 months, Innoviva has paid $62.16 million in taxes.
| Income Tax | 62.16M |
| Effective Tax Rate | 14.82% |
Stock Price Statistics
The stock price has increased by +14.48% in the last 52 weeks. The beta is 0.34, so Innoviva's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +14.48% |
| 50-Day Moving Average | 22.05 |
| 200-Day Moving Average | 21.60 |
| Relative Strength Index (RSI) | 44.14 |
| Average Volume (20 Days) | 755,729 |
Short Selling Information
The latest short interest is 7.02 million, so 9.51% of the outstanding shares have been sold short.
| Short Interest | 7.02M |
| Short Previous Month | 6.65M |
| Short % of Shares Out | 9.51% |
| Short % of Float | 10.14% |
| Short Ratio (days to cover) | 7.38 |
Income Statement
In the last 12 months, Innoviva had revenue of $440.00 million and earned $357.24 million in profits. Earnings per share was $4.30.
| Revenue | 440.00M |
| Gross Profit | 318.38M |
| Operating Income | 167.42M |
| Pretax Income | 419.40M |
| Net Income | 357.24M |
| EBITDA | 203.00M |
| EBIT | 162.58M |
| Earnings Per Share (EPS) | $4.30 |
Balance Sheet
The company has $579.06 million in cash and $258.45 million in debt, with a net cash position of $320.60 million or $4.34 per share.
| Cash & Cash Equivalents | 579.06M |
| Total Debt | 258.45M |
| Net Cash | 320.60M |
| Net Cash Per Share | $4.34 |
| Equity (Book Value) | 1.23B |
| Book Value Per Share | 16.98 |
| Working Capital | 706.30M |
Cash Flow
In the last 12 months, operating cash flow was $191.49 million and capital expenditures -$2.05 million, giving a free cash flow of $189.44 million.
| Operating Cash Flow | 191.49M |
| Capital Expenditures | -2.05M |
| Depreciation & Amortization | 26.60M |
| Net Borrowing | -25,000 |
| Free Cash Flow | 189.44M |
| FCF Per Share | $2.57 |
Margins
Gross margin is 72.36%, with operating and profit margins of 38.05% and 81.19%.
| Gross Margin | 72.36% |
| Operating Margin | 38.05% |
| Pretax Margin | 95.32% |
| Profit Margin | 81.19% |
| EBITDA Margin | 46.14% |
| EBIT Margin | 36.95% |
| FCF Margin | 43.06% |
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 22.93% |
| FCF Yield | 12.16% |
Analyst Forecast
The average price target for Innoviva is $35.50, which is 68.17% higher than the current price. The consensus rating is "Buy".
| Price Target | $35.50 |
| Price Target Difference | 68.17% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 8.55% |
| EPS Growth Forecast (3Y) | 12.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |